AGTC Trademark

Trademark Overview

On Tuesday, September 24, 2013, a trademark application was filed for AGTC with the United States Patent and Trademark Office. The USPTO has given the AGTC trademark a serial number of 86072673. The federal status of this trademark filing is REGISTERED as of Tuesday, July 31, 2018. This trademark is owned by Applied Genetic Technologies Corporation. The AGTC trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for use in the prevention and treatment of human diseases, namely, pulmonary diseases, lysosomal storage disorders, central nervous system disorders, including diseases of the brain and eyes, and gene therapy

Research and development in the field of genomics, gene therapy, pharmaceuticals and vaccines
agtc

General Information

Serial Number86072673
Word MarkAGTC
Filing DateTuesday, September 24, 2013
Status700 - REGISTERED
Status DateTuesday, July 31, 2018
Registration Number5530418
Registration DateTuesday, July 31, 2018
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 7, 2015

Trademark Statements

Description of MarkThe mark consists of a design of a double helix followed by the letters "AGTC" in stylized font.
Goods and ServicesPharmaceuticals for use in the prevention and treatment of human diseases, namely, pulmonary diseases, lysosomal storage disorders, central nervous system disorders, including diseases of the brain and eyes, and gene therapy
Pseudo MarkAPPLIED GENETIC TECHNOLOGIES CORPORATION
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesResearch and development in the field of genomics, gene therapy, pharmaceuticals and vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 30, 2013
Primary Code005
First Use Anywhere DateThursday, June 4, 2015
First Use In Commerce DateThursday, June 4, 2015
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 30, 2013
Primary Code042
First Use Anywhere DateMonday, June 4, 2018
First Use In Commerce DateMonday, June 4, 2018

Trademark Owner History

Party NameApplied Genetic Technologies Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAlachua, FL 32615
Party NameApplied Genetic Technologies Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAlachua, FL 32615
Party NameApplied Genetic Technologies Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlachua, FL 32615

Trademark Events

Event DateEvent Description
Monday, July 31, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 31, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, June 28, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 27, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 6, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, June 4, 2018USE AMENDMENT FILED
Monday, June 4, 2018TEAS STATEMENT OF USE RECEIVED
Thursday, November 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 15, 2017SOU EXTENSION 5 GRANTED
Monday, November 13, 2017SOU EXTENSION 5 FILED
Monday, November 13, 2017TEAS EXTENSION RECEIVED
Tuesday, May 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 26, 2017SOU EXTENSION 4 GRANTED
Friday, May 26, 2017SOU EXTENSION 4 FILED
Friday, May 26, 2017TEAS EXTENSION RECEIVED
Tuesday, November 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 26, 2016SOU EXTENSION 3 GRANTED
Tuesday, November 22, 2016SOU EXTENSION 3 FILED
Tuesday, November 22, 2016TEAS EXTENSION RECEIVED
Thursday, June 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 29, 2016SOU EXTENSION 2 GRANTED
Tuesday, May 17, 2016SOU EXTENSION 2 FILED
Thursday, June 16, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 17, 2016TEAS EXTENSION RECEIVED
Friday, December 4, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 2, 2015SOU EXTENSION 1 GRANTED
Wednesday, December 2, 2015SOU EXTENSION 1 FILED
Wednesday, December 2, 2015TEAS EXTENSION RECEIVED
Tuesday, June 2, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 7, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 7, 2015PUBLISHED FOR OPPOSITION
Wednesday, March 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 27, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 26, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 26, 2015ASSIGNED TO LIE
Tuesday, August 5, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 5, 2014LETTER OF SUSPENSION E-MAILED
Tuesday, August 5, 2014SUSPENSION LETTER WRITTEN
Tuesday, July 15, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 14, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 14, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 14, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 14, 2014NON-FINAL ACTION E-MAILED
Tuesday, January 14, 2014NON-FINAL ACTION WRITTEN
Tuesday, January 7, 2014ASSIGNED TO EXAMINER
Tuesday, October 1, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, September 30, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 27, 2013NEW APPLICATION ENTERED

Related Keywords

agtc diseases therapy pharmaceuticals gene disorders eyes brain research vaccines genomics